科翔股份(300903) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2025 was ¥920,878,245.26, representing a slight increase of 0.06% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥57,671,313.17, a decrease of 24.66% year-on-year, while the net profit after deducting non-recurring gains and losses was -¥60,060,835.04, down 27.58%[5]. - Total operating revenue for the current period reached ¥2,726,704,839.67, an increase from ¥2,476,610,211.42 in the previous period, reflecting a growth of approximately 10.1%[21]. - The company reported a net loss of ¥299,624,879.51 in retained earnings, compared to a loss of ¥179,919,415.95 in the previous period[20]. - The net profit for the current period is -133,875,468.54, compared to -187,168,902.77 in the previous period, showing an improvement of approximately 28.5%[22]. - Operating profit for the current period is -157,054,538.74, an improvement from -245,207,528.16 in the previous period, indicating a reduction in losses by about 36%[22]. - Total comprehensive income for the current period is -133,875,468.54, compared to -187,168,902.77 in the previous period, reflecting a 28.5% improvement[23]. - Basic and diluted earnings per share for the current period are both -0.2905, an improvement from -0.4227 in the previous period[23]. Cash Flow and Assets - The operating cash flow net amount for the year-to-date was ¥98,961,391.31, showing a significant increase of 181.96% compared to the previous year[5]. - The net cash flow from operating activities for the first nine months of 2025 was ¥98,961,391.31, a turnaround from -¥120,737,270.35 in the same period last year[9]. - Cash flow from operating activities generated a net amount of 98,961,391.31, a significant recovery from -120,737,270.35 in the previous period[23]. - Cash and cash equivalents decreased to ¥356,937,470.27 from ¥838,662,628.63, representing a decline of approximately 57.5%[18]. - Cash and cash equivalents at the end of the period stand at 264,068,642.93, down from 449,378,537.24 at the end of the previous period[24]. - Cash flow from investing activities resulted in a net outflow of -231,442,705.76, worsening from -132,830,803.91 in the previous period[24]. - Cash flow from financing activities resulted in a net outflow of -260,101,695.75, compared to a net inflow of 295,613,698.73 in the previous period[24]. - Total assets at the end of the reporting period were ¥6,607,122,645.73, a decrease of 10.11% from the end of the previous year[5]. - Total assets decreased to ¥6,607,122,645.73 from ¥7,350,593,212.93, a decline of about 10.1%[20]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 28,528[11]. - The largest shareholder, Zheng Xiaorong, holds 15.01% of shares, totaling 62,257,231 shares, with 39,050,000 shares pledged[11]. - The second-largest shareholder, Tan Dong, holds 11.60% of shares, totaling 48,104,750 shares, with 1,000,000 shares pledged[11]. - The company has a total of 2,711,520 shares repurchased, representing 0.65% of the total share capital[12]. - The total number of shares with limited sales at the end of the period is 86,299,620 shares[16]. - The company has not reported any changes in the top 10 shareholders due to margin trading activities[13]. - The company has a total of 86,373,978 shares with restrictions at the beginning of the period, with 409,810 shares released and 335,452 shares added during the period[16]. - The company has a total of 4.44% of shares held by Shenzhen Kexiang Capital Management Co., Ltd., totaling 18,396,614 shares[11]. - The company has not disclosed any other significant shareholder relationships or actions[12]. - The company has a total of 0 shares of preferred stock and no preferred shareholders listed[13]. Operating Costs and Expenses - Total operating costs amounted to ¥2,889,793,034.12, up from ¥2,730,734,477.35, indicating an increase of about 5.8%[21]. - The company's financial expenses increased by 33.17% to ¥34,023,884.05, primarily due to higher interest expenses[9]. - Research and development expenses rose to ¥154,915,083.56 from ¥143,824,870.34, an increase of approximately 7.7%[21]. - The company incurred credit impairment losses of 9,581,516.55, compared to a gain of 7,874,427.50 in the previous period[22]. Inventory and Receivables - Accounts receivable decreased to ¥1,635,375,140.39 from ¥1,762,980,616.63, a reduction of about 7.2%[18]. - Inventory increased to ¥546,713,040.49 from ¥475,959,642.82, showing a rise of approximately 14.8%[18]. - The company experienced a 54.22% increase in notes receivable, reaching ¥102,040,270.14, due to an increase in bank acceptance bill collections[8].